COVID - search results
If you're not happy with the results, please do another search
A Molecular Decoy Provides 100% Protection against COVID-19 in Lab Studies
A molecular "decoy," a version of ACE2, protected 100 percent of study mice from COVID-19 when they were infected with an otherwise lethal dose of SARS-CoV-2.
Biomarkers Found for Rare Inflammatory Syndrome Linked to COVID-19 in Children
Using next generation sequencing, biomarkers of COVID-linked multisystem inflammatory syndrome (MIS-C) have been found. The biomarkers are linked to organ damage.
Gut Bacteria Impact COVID-19 Vaccine Response
Japanese research suggests that the digestion of fucose sugar by gut bacteria could impact the immune response to COVID-19 mRNA vaccines.
COVID-19 Increases Risk of Developing Diabetes
Infection with SARS-CoV-19 increases the risk of developing incident diabetes after recovering from the infection. Naveed Janjua from the British Columbia Centre for Disease Control, and colleagues report that 3–5% of incident diabetes cases in the study could be attributed to COVID-19.
Finnish Researchers Develop Nasal Spray That Protects against COVID
A team of researchers at the University of Helsinki, Finland, report they have developed a molecule that can be administered nasally to prevent the development of COVID-19 symptoms by all known variants of the SARS-CoV-2 virus.
Risk of Venous Thromboembolism after COVID-19 Low in Non-Hospitalized Patients
Overall risks of venous thromboembolism after COVID-19 are low in patients with less severe infections who do not require hospitalization.
New Drug Class Against COVID-19 Identified
Researchers have identified a potential new class of oral, antiviral drugs that could combat emerging coronaviruses and drug-resistant variants.
Researchers Develop First Nasal Monoclonal Antibody against COVID-19
Scientists use the nasal monoclonal antibody “Foralumab” to successfully decrease inflammation in patients with COVID-19.
Breath Test Detects Even COVID Variants
A test using a puff of breath might be used to discern even variants of COVID-19 from non-COVID respiratory diseases.
Presence of Specific Antibodies Could Be Protective against Long COVID
The presence of autoantibodies against inflammatory chemokines after COVID-19 could protect against the development of long COVID.